Medical Daily | Cutting Edge Cancer Therapy From Immunocore Receives $212M In Funding ... Medical Daily Typical next-generation anti-cancer treatments, such as Herceptin for breast cancer, are monoclonal antibodies (mAB) that are only one type of antibody that stick to a specific receptor on the surface of cancer cells. In the case of Herceptin, the ... |
